# Recce Pharmaceuticals Ltd (RECEF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RECEF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 562.5K | $ -30.25M | $ -23.78M | $ 11.26M | $ -18.61M |
| 2024 | $ 7.11M | $ -18.37M | $ -13.79M | $ 4.74M | $ -4.99M |
| 2023 | $ 7.16M | $ -12.01M | $ -9.71M | $ 198.8K | $ 534.2K |
| 2022 | $ 3.50M | $ -17.29M | $ -16.47M | $ 127.5K | $ 1.24M |
| 2021 | $ 1.19M | $ -9.91M | $ -8.78M | $ 131.4K | $ 15.52M |
| 2020 | $ 832.7K | $ -15.90M | $ -9.31M | $ 238.6K | $ 23.33M |
| 2019 | $ 1.32M | $ -3.77M | $ -3.73M | $ 158.2K | $ 4.72M |
| 2018 | $ 1.93M | $ -2.12M | $ -2.05M | $ 456.0K | $ -370.4K |
| 2017 | $ 721.0K | $ -3.49M | $ -3.65M | $ 128.9K | $ 959.4K |
| 2016 | $ 52.0K | $ -2.88M | $ -3.14M | $ 0 | $ 2.21M |
| 2015 | $ 330.6K | $ -5.81M | $ -1.12M | $ 95.6K | $ 4.54M |
| 2014 | $ 64.8K | $ -181.8K | $ 7.6K | $ 0 | $ -56.2K |
| 2013 | $ 67.0K | $ -388.1K | $ 7.9K | $ 0 | $ -75.2K |
| 2012 | $ 272 | $ -206.0K | $ 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.60 |
| Liabilities / Eq | -1.11 |
| Current Ratio | 0.08 |

## Other views

- [Metrics](https://sponda.capital/en/RECEF.md)
- [Charts](https://sponda.capital/en/RECEF/charts.md)
- [Compare](https://sponda.capital/en/RECEF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.